Back to search
Streptococcal Pneumonia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Streptococcal Pneumonia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Streptococcal Pneumonia trials you may qualify forThis phase II trial tests whether the pneumococcal pneumonia vaccine series (PCV20 and PPSV23) works to mount an effective immune response in patients with chro…
The study will evaluate the safety, tolerability, and immunogenicity of VAX-31 in adults ≥50 years of age.
The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle in…
Background: China's healthcare system for children faces significant challenges, particularly due to the limited pediatric service capacity of primary healthcar…
Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital…
A complex interaction between demographic, environmental and genetic mechanisms impact the onset, severity and outcome of ILD-SARDs through dysregulation of the…
Antibody deficiencies and complement deficiencies are the most frequent Primary immunodeficiencies (PIDs) in adults, and are associated with greatly increased s…
The main objective of the study is to evaluate the persistence of the immunoglobulin G (IgG) antibody responses, specific to Alpha-like protein CN (AlpCN), Ribo…
This is a Phase 3, randomized, double-blind study to evaluate the safety and immunogenicity of VAX-31 and seasonal influenza vaccine in pneumococcal-naïve adult…